Susan Sabo-Wagner, MSN, RN, OCN, executive director of clinical strategy for Oncology Consultants of Houston, Texas, talked about the importance of having adequate support not only from clinical staff, but also emotional and moral support at home.
Having support at home when faced with a cancer diagnosis is "critical", said Susan Sabo-Wagner, MSN, RN, OCN, executive director of Clinical Strategy for Oncology Consultants.
Transcript
Can you speak to what makes for a successful at-home assessment, when people need care at home or support at home for cancer care, since so much care is moving back home?
Number one is to have someone who can support at home, be it a spouse, adult child, neighbor, or somebody. Even if you have a good home health care company or an aide that can go into the home, they can only be there however often their insurance will allow or even if they're paying privately, it is almost 100% necessary for at least somebody to be a caregiver. Of course, that depends on the patient [and] how well they do.
Even from a moral support or emotional support standpoint, it's really difficult to walk a full cancer diagnosis completely on your own without having someone that you can really depend on. There's definitely days where you don't feel well. My goodness, last week with my flu, I missed that I had somebody to feed my kids because there was a couple of days where I just couldn't. That's really what it's like for a cancer patient. There are days when you just can't, and it's either a physical feeling or it's an emotional feeling. To have somebody who can do those things, who can lift you up, that's critical.
Beyond that, we've made a lot of good connections with different companies throughout the city. We are in 12 locations in Houston for medical oncology, so we're all over the place. It's a big city with a lot of options, and we've been around and doing this for quite a long time. So, we know for the most part, who are the “good ones” and who we can really rely on. There's a lot of different insurance payers that we're dealing with; it's just as diverse within the payer market. So, this insurance company may not be able to have this particular home health, but we can work around in this way.
Our nurse navigators are very good about understanding because they both have worked in home health, as well. They understand how the insurance works, how home health works, how they can get the most benefit for each patient, how you write orders, and how you get things approved. They work very well with the home health companies that we’re mostly working with.
Managed Care Cast Presents: BTK Inhibitors in Treatment-Naive Patients With CLL and MCL
December 26th 2024A trio of experts discuss the treatment of chronic lymphocytic leukemia (CLL) and mantle cell lymphoma (MCL) with Bruton tyrosine kinase (BTK) inhibitors, including cost considerations.
Listen
HS Treatment Goals: Better Quality of Life, Not Just Control
January 3rd 2025For part 3 of our discussion with Chris Sayed, MD, we tackle several important topics in the hidradenitis suppurative (HS) and inflammatory disease space: patient quality of life, medication and treatment goals, and the possibility of a cure.
Read More
Dr Yehuda Handelsman: DCRM Guidelines Are Shaping Integrated, Global CRM Care
January 3rd 2025In part 2 of our interview, Yehuda Handelsman, MD, discusses how cardiorenalmetabolic (CRM) disease management is advancing with the 2022 Diabetes, Cardiorenal, and Metabolic (DCRM) multispecialty practice recommendations and the updated DCRM 2.0 guidelines.
Read More
Stripped of Fucose, Powerful Monoclonal Antibody Shows Promising Results in MDS Dosing Study
January 2nd 2025Nicole Grieselhuber, MD, PhD, of The Ohio State University, discusses results from Part D of a dosing study involving patients with previously untreated higher-risk myelodysplastic syndrome (MDS) who were treated with a combination of SEA-CD70 and azacitidine.
Read More